OMEROS CORP

CEO Demopulos Exercises $17.88 Stock Option, Boosting Investor Confidence in OMEROS’s 124% Growth Target

CEO Demopulos exercises 500k performance options, boosting insider confidence in OMEROS’s bullish run and long‑term growth prospects.

OMEROS CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

30/10/2026, 22:20

3 minutes to read

OMEROS Insider Trades Show Structured Liquidity Management, Not Speculation

Inside OMEROS trading moves reveal disciplined liquidity strategy, not market hints—focus on upcoming clinical milestones, regulatory wins, and partnership prospects.

OMEROS CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

25/09/2026, 03:16

3 minutes to read